Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-05-19 11:51 Tx date 2022-05-17 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,999
+66,665 vol $0.15 each |
86,665 | |
Filed 2021-08-11 16:43 Tx date 2021-08-05 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+10,000 vol |
20,000 | |
Filed 2021-08-11 16:42 Tx date 2021-08-05 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,350
+5,000 vol $1.47 each |
10,000 | |
Filed 2021-05-27 11:43 Tx date 2021-05-25 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$96,525
+82,500 vol $1.17 each |
137,500 | |
Filed 2020-10-09 13:58 Tx date 2020-10-01 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
Filed 2020-10-09 13:57 Tx date 2020-10-01 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
55,000 | ||
Filed 2020-10-09 13:56 Tx date 2020-10-01 |
$CRBK
Carebook Technologies Inc. (formerly Pike Mountain Minerals Inc.) |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
Filed 2017-09-19 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,089
+813 vol $8.72 each |
168,717 | |
Filed 2017-06-20 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,244
+737 vol $9.83 each |
167,904 | |
Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+74,010 vol |
419,010 | |
Filed 2017-03-17 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,107
+589 vol $10.37 each |
167,167 | |
Filed 2016-12-23 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+10,000 vol $10.00 each |
166,578 | |
Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,420
+644 vol $9.97 each |
156,578 | |
Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,636
+404 vol $9.00 each |
155,934 | |
Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,638
+425 vol $8.56 each |
155,530 | |
Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+12,500 vol $8.00 each |
155,105 | |
Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,116
+415 vol $7.51 each |
142,605 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
345,000 | |
Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,635
+486 vol $7.48 each |
142,190 | |
Filed 2015-09-23 Tx date 2015-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,110
+412 vol $7.55 each |
141,704 | |
Filed 2015-06-18 Tx date 2015-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,118
+443 vol $7.04 each |
141,292 |